Curaleaf expands advertising in New Jersey

Curaleaf started serving New Jersey adult customers to its Bellmawr location in april

WAKEFIELD, Mass., May 24, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a Leading International Provider of Cannabis Consumer Products, to Begin Adult Use Sales to his Edgewater Park, New Jersey dispensary on May 25. Located at 4237 US-130, Curaleaf Edgewater Park is now the company’s second location selling adult-use cannabis in the Garden State.

Curaleaf is dedicated to providing superior products and reliable retail experiences to adult customers while continuing to serve patients enrolled in the state medical program. Curaleaf Edgewater Park will implement additional measures to prioritize approved medical patients, including access to private consultation areas, a secure online ordering system, exclusive paylines and designated parking spaces. In order to optimize accessibility to patients, the dispensary will also offer two hours of exclusively medical shopping per day.

New Jersey expected to be one of the largest cannabis markets in the country. Curaleaf Edgewater Park and Curaleaf Bellmawr are the company’s first locations to serve recreational customers since the New Jersey Cannabis Regulatory Commission cleared adult sales in April.

“After a successful launch for adults in April, we are excited to expand our adult footprint, allowing us to serve even more New Jersey consumers,” said Matt Darin, CEO of Curaleaf. “I would like to thank the Edgewater City Park for their partnership and for welcoming us so graciously into the community. Curaleaf is committed to ensuring that patients and consumers receive quality products and services as they embark on their journey with cannabis. »

Edgewater Park is now the 13th dispensary licensed to sell adult-use cannabis in the Garden State. For more information about Curaleaf locations, patient resources and products in New Jerseyplease visit

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer cannabis products whose mission is to improve lives by bringing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for its quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility in medical markets. and adults. In United States, Curaleaf currently operates in 22 states with 133 dispensaries, 26 cultivation sites and employs more than 5,700 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, combining pioneering science and research with state-of-the-art cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “proposes”, “plans”, “intends” , “anticipates” or “believes”, or variations of these words and expressions, or by the use of words or expressions indicating that certain actions, events or results can, might, might occur or be achieved. More particularly and without limitation, this press release contains forward-looking statements and information regarding the introduction of adult sales at Curaleaf Edgewater Park. Such forward-looking statements and information reflect the current beliefs of management and are based on assumptions made by and information currently available to the company with respect to the subject matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information on these assumptions and risks and uncertainties is contained in the “Risk Factors and Uncertainties” section of the Company’s most recently filed Annual Information Form. March 9, 2022which is available under the Company’s SEDAR profile at, and in other filings the Company has made and may make in the future with applicable securities authorities. The forward-looking statements contained herein are made only as of the date of this press release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place significant reliance on any forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved of the contents of this press release.

Curaleaf Holdings, Inc.
Investor Relations
[email protected]

Curaleaf Holdings, Inc.
Tracy Bradyvice president of corporate communications
[email protected]

Show original content:

SOURCE Curaleaf Holdings, Inc.

Comments are closed.